Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vein graft failure

N L Mills1, C T Everson

  • 1Mills Cardiovascular, Physicians Center, New Orleans, LA 70072, USA.

Current Opinion in Cardiology
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Saphenous vein graft failure, a major cause of bypass reoperation, is poorly understood. Research highlights saphenous vein valves and graft preparation as key factors, with arterial grafts likely increasing in use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comprehensive validation of early diagnostic algorithms for myocardial infarction in the emergency department.

QJM : monthly journal of the Association of Physicians·2023
Same author

Machine learning to predict myocardial injury and death after non-cardiac surgery.

Anaesthesia·2023
Same author

Predictors of UK healthcare worker burnout during the COVID-19 pandemic.

QJM : monthly journal of the Association of Physicians·2021
Same author

Dynamic Changes in High-Sensitivity Cardiac Troponin I in Response to Anthracycline-Based Chemotherapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2019
Same author

Scientific Business Abstracts of the 112th Annual Meeting of the Association of Physicians of Great Britain and Ireland.

QJM : monthly journal of the Association of Physicians·2019
Same author

Radial artery vasomotor function following transradial cardiac catheterisation.

Open heart·2016
Same journal

An integrative approach to patient selection for mitral transcatheter edge-to-edge repair in secondary mitral regurgitation.

Current opinion in cardiology·2026
Same journal

Rebooting blood vessel repair: implications of the SEMA-VR CardioLink-15 trial.

Current opinion in cardiology·2026
Same journal

Advancements in wearable technology for heart failure patients.

Current opinion in cardiology·2026
Same journal

Minimally invasive approaches to coronary artery bypass grafting: techniques, current evidence, and future directions.

Current opinion in cardiology·2026
Same journal

Advances in artificial intelligence for the evaluation of mitral regurgitation.

Current opinion in cardiology·2026
Same journal

Role of nutritional interventions to reduce cardiometabolic disease burden in the community.

Current opinion in cardiology·2026
See all related articles

Area of Science:

  • Cardiovascular Surgery
  • Vascular Biology
  • Graft Patency Research

Background:

  • Saphenous vein graft failure is a primary driver for coronary artery bypass reoperation, incurring significant economic costs.
  • The variability in vein graft disease progression, with some grafts remaining disease-free while others develop atherosclerosis, remains poorly understood.
  • Saphenous vein valves have emerged as a focal point, with disease progression often accentuated around them and more intense atherosclerosis observed distally.

Purpose of the Study:

  • To explore the enigmatic factors contributing to saphenous vein graft failure.
  • To investigate the role of saphenous vein valves and hypercoagulable states in graft disease.
  • To evaluate current strategies for maintaining graft patency and predict early graft outcomes.

Main Methods:

Related Experiment Videos

  • Review of existing literature on saphenous vein graft failure mechanisms.
  • Analysis of angiographic data showing disease patterns around valves.
  • Consideration of saphenous vein graft biopsy for predicting early results.
  • Exploration of hypercoagulable states and pharmacologic interventions.

Main Results:

  • Vein graft disease is consistently more severe around saphenous vein valves and in the segments distal to them.
  • Saphenous vein graft biopsy may offer predictive value for early graft outcomes.
  • Pharmacologic agents for maintaining graft patency have yielded disappointing results, with aspirin remaining the primary choice.
  • Surgical injury during graft preparation is directly linked to neointimal thickening and smooth muscle cell proliferation.

Conclusions:

  • Understanding saphenous vein graft failure requires further investigation into factors like valves and hypercoagulability.
  • Current pharmacologic and surgical preparation strategies have limitations in preventing graft disease.
  • The challenges in translating animal data and in vitro findings to human physiology suggest limited immediate solutions.
  • An increased utilization of arterial grafts is anticipated in the near future due to the persistent issues with saphenous vein grafts.